nexvigilant/.true - Page 3

ksb-d03-k0023

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Multi-organ involvement, diagnostic criteria...

Langue du texte source : anglais

ksb-d03-k0024

Autoimmune Syndromes: Drug-induced lupus, vasculitis, autoantibody development...

Langue du texte source : anglais

ksb-d03-k0025

Immunosuppression: Increased infection risk, malignancy development, immune reconstitution...

Langue du texte source : anglais

ksb-d03-k0026

Machine Learning Algorithms: Supervised learning for ADR classification, unsupervised clustering for pattern discovery...

Langue du texte source : anglais

ksb-d03-k0027

Deep Learning Applications: Neural networks for complex pattern recognition, image analysis for dermatological ADRs...

Langue du texte source : anglais

ksb-d03-k0028

Natural Language Processing: Automated narrative analysis, symptom extraction, severity assessment...

Langue du texte source : anglais

ksb-d03-k0029

Computer Vision: Medical image analysis, dermatological ADR recognition, laboratory result interpretation...

Langue du texte source : anglais

ksb-d03-k0030

Ensemble Methods: Combining multiple AI approaches for improved accuracy and robustness...

Langue du texte source : anglais

ksb-d03-k0031

Risk Prediction Models: Patient-specific ADR risk assessment using clinical and genetic factors...

Langue du texte source : anglais

ksb-d03-k0032

Temporal Pattern Analysis: AI detection of ADR development timelines and progression patterns...

Langue du texte source : anglais

ksb-d03-k0033

Severity Prediction: Algorithms predicting ADR severity and outcome based on early presentations...

Langue du texte source : anglais

ksb-d03-k0034

Drug Interaction Modeling: AI-based prediction of interaction-related ADRs and complications...

Langue du texte source : anglais

ksb-d03-k0035

Population-Based Modeling: Epidemiological pattern recognition across diverse patient populations...

Langue du texte source : anglais

ksb-d03-k0036

Electronic Health Record Integration: Automated ADR detection from clinical data streams...

Langue du texte source : anglais

ksb-d03-k0037

Wearable Device Integration: Continuous monitoring for cardiovascular and neurological ADRs...

Langue du texte source : anglais

ksb-d03-k0038

Laboratory Result Analysis: Automated interpretation of biomarker changes indicating ADRs...

Langue du texte source : anglais

ksb-d03-k0039

Pharmacokinetic Modeling: AI-enhanced dose optimization and ADR risk minimization...

Langue du texte source : anglais

ksb-d03-k0040

Alert Generation: Intelligent warning systems for important ADR development...

Langue du texte source : anglais

ksb-d03-k0089

AI Pattern Detection in Organ-System ADRs: Mastery of AI-enhanced pattern recognition for identifying organ-system-specific ADR signatures incl...

Langue du texte source : anglais

ksb-d03-k0090

AI Toxicity Prediction Models: Comprehensive understanding of AI-based toxicity prediction including in silico ADMET modeling, stru...

Langue du texte source : anglais

ksb-d03-k0091

AI Multi-System ADR Detection: Understanding of AI systems for detecting multi-organ ADR patterns including cross-system correlatio...

Langue du texte source : anglais

ksb-d03-k0092

AI-Enhanced Rare ADR Identification: Mastery of AI approaches for identifying rare ADRs including small sample learning techniques, anoma...

Langue du texte source : anglais

ksb-d04-k0001

ICH E2A Guidelines: Definitions of adverse events, serious adverse events, and reporting timelines...

Langue du texte source : anglais

ksb-d04-k0002

ICH E2B Standards: Electronic transmission standards, data elements, and technical specifications...

Langue du texte source : anglais

ksb-d04-k0003

ICH E2D Guidelines: Post-marketing expedited reporting requirements and procedures...

Langue du texte source : anglais

ksb-d04-k0004

MedDRA Implementation: Medical terminology, coding hierarchy, and version management protocols...

Langue du texte source : anglais

ksb-d04-k0005

Regional Variations: FDA (FAERS), EMA (EudraVigilance), PMDA (J-PRISM), Health Canada differences...

Langue du texte source : anglais

ksb-d04-k0006

15-Day Safety Reports: Serious, unexpected adverse events in marketed products...

Langue du texte source : anglais

ksb-d04-k0007

7-Day Fatal/Life-Threatening: Urgent reporting requirements for the most serious events...

Langue du texte source : anglais

ksb-d04-k0008

Non-Expedited Reporting: Periodic safety update reports and aggregate data submission...

Langue du texte source : anglais

ksb-d04-k0009

Follow-up Information: Additional data collection, timeline requirements, null reports...

Langue du texte source : anglais

ksb-d04-k0010

Regulatory Timeline Management: Tracking systems, deadline calculation, compliance monitoring...

Langue du texte source : anglais

ksb-d04-k0011

Core Data Sheet Requirements: Minimum essential information for valid case reports...

Langue du texte source : anglais

ksb-d04-k0012

Patient Information: Demographics, medical history, concomitant medications, relevant laboratory data...

Langue du texte source : anglais

ksb-d04-k0013

Suspect Product Details: Dosage, administration route, start/stop dates, indication, batch information...

Langue du texte source : anglais

ksb-d04-k0014

Event Information: Description, onset timing, severity, outcome, causality assessment, actions taken...

Langue du texte source : anglais

ksb-d04-k0015

Reporter Information: Healthcare professional vs. consumer, contact details, follow-up accessibility...

Langue du texte source : anglais

ksb-d04-k0016

Source Document Review: Primary information evaluation, quality assessment, completeness verification...

Langue du texte source : anglais

ksb-d04-k0017

Initial Triage Protocols: Expedited vs. non-expedited determination, regulatory scope assessment...

Langue du texte source : anglais

ksb-d04-k0018

Data Entry Standards: Systematic information capture, field validation, quality checks...

Langue du texte source : anglais